Last reviewed · How we verify

NCT05866952: PASC VQ

Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection

Recruiting now Last updated 20 July 2025
What this trial tests

trial testing Computed Tomography of the Chest in Post-Acute COVID-19 in 40 participants. Currently enrolling.

Timeline
5 June 2023
Primary endpoint
31 May 2026
31 December 2026

Quick facts

Lead sponsorTufts Medical Center
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment40
Start date5 June 2023
Primary completion31 May 2026
Estimated completion31 December 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Tufts Medical Center

Who can join

Adults 18 to 99, any sex, with Post-Acute COVID-19 or Post COVID-19 Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective cohort study to evaluate the utility of quantitative CT analysis to assess ventilation and perfusion defects in patients with Post-acute Sequelae of SARS-CoV-2 (PASC) and functional limitations

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Post-Acute COVID-19

Currently open trials in the same condition.

Other Tufts Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05866952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing